Gene · 10403
Papers2,370
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,370
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting NUF2 suppresses gastric cancer progression through G2/M phase arrest and apoptosis induction. | Chin Med J (Engl) | 2024 | 39193700 | PubTator, text mining | PubMed |
| Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma. | Diagn Pathol | 2024 | 39095799 | PubTator, text mining | PubMed |
| The Molecular Mechanism of Aurora-B Regulating Kinetochore-Microtubule Attachment in Mitosis and Oocyte Meiosis. | Cytogenet Genome Res | 2024 | 39068909 | PubTator, text mining | PubMed |
| Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis. | Biomed Res Int | 2024 | 39045407 | PubTator, text mining | PubMed |
| NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single-cell RNA-seq and in vitro experiment. | CNS Neurosci Ther | 2024 | 39021287 | PubTator, text mining | PubMed |
| Decoy peptides that inhibit TNF signaling by disrupting the TNF homotrimeric oligomer. | FEBS J | 2024 | 39003565 | PubTator, text mining | PubMed |
| Flood risk assessment of the Garita River in the urban zone of San Luis Potosí City, by hydrodynamic modeling. | Sci Rep | 2024 | 38987570 | PubTator, text mining | PubMed |
| Knockdown of NUF2-derived exosomes can inhibit the migration and autophagy of BC cells and improve resistance to doxorubicin. | Tissue Cell | 2024 | 38964084 | PubTator, text mining | PubMed |
| WZ-3146 acts as a novel small molecule inhibitor of KIF4A to inhibit glioma progression by inducing apoptosis. | Cancer Cell Int | 2024 | 38937742 | PubTator, text mining | PubMed |
| Developing a Predictive Model for Metastatic Potential in Pancreatic Neuroendocrine Tumor. | J Clin Endocrinol Metab | 2024 | 38817124 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation of microtubule-binding proteins in the regulation of spindle assembly. | Cell Prolif | 2024 | 38736355 | PubTator, text mining | PubMed |
| NDC80 Kinetochore Complex Serves as a Potential Prognostic Predictor and Correlates with Immune Infiltrates in Epithelial Ovarian Cancer Patients. | Int J Gen Med | 2024 | 38711823 | PubTator, text mining | PubMed |
| Spindle component 25 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis. | Sci Rep | 2024 | 38605119 | PubTator, text mining | PubMed |
| NUF2 regulated the progression of hepatocellular carcinoma through modulating the PI3K/AKT pathway via stabilizing ERBB3. | Transl Oncol | 2024 | 38507923 | PubTator, text mining | PubMed |
| Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction. | Cell Death Dis | 2024 | 38493150 | PubTator, text mining | PubMed |
| Binding Site Maturation Modulated by Molecular Density Underlies Ndc80 Binding to Kinetochore Receptor CENP-T. | bioRxiv | 2024 | 38464265 | PubTator, text mining | PubMed |
| SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression. | Front Biosci (Landmark Ed) | 2024 | 38420826 | PubTator, text mining | PubMed |
| KNL1 and NDC80 represent new universal markers for the detection of functional centromeres in plants. | Chromosome Res | 2024 | 38403686 | PubTator, text mining | PubMed |
| Coregulation of NDC80 Complex Subunits Determines the Fidelity of the Spindle-Assembly Checkpoint and Mitosis. | Mol Cancer Res | 2024 | 38324016 | PubTator, text mining | PubMed |
| Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms. | Sci Rep | 2024 | 38308077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10403/papers?page=6